Supplementary Figure S4 from JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC

Authors:

Open Access

Publisher website

17 June 2026

other
Published by American Association for Cancer Research (AACR)

DOI:10.1158/1078-0432.32709134

Abstract

Antitumor activity of JIN-A02 in PC9 cells-driven intracranial tumor models

Keywords